Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1944
result was found. Results that relate to
R
Optimization of inclusion process for Ramulus cinnamomi volatile oil using Plackett-Burman design combined with Box-Behnken response surface methodology
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1108-1118.
4827 times
590 times
JIANG Mingyue
QI Shuang
CAO Jixiang
LIU Zhenyuan
WU Tianqi
WANG Changqi
BAI Xue
HAN Pei
ZHANG Wei
R
amulus cinnamomi volatile oil
Inclusion p
r
ocess
Plackett-Bu
r
man
Box-Behnken
r
esponse su
r
face analysis
Details
Quality evaluation of Zhike Huatan mixture based on HPLC fingerprint combined with chemometrics
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1119-1125.
4879 times
534 times
GUO Hongxing
WANG Xianyong
CHEN Fei
LUO Yiyuan
Zhike Huatan mixtu
r
e
Finge
r
p
r
int
Chemomet
r
ics
Quality evaluation
Details
Preparation and characterization of hyaluronic acid-rebamipide conjugate and the conjugate self-assembled nanoparticles
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1126-1131.
5137 times
560 times
MAO Kaifan
XUE Song
WANG Lili
LIU Zhengping
YANG Xuehua
ZHANG Hongqian
WANG Yingchao
WANG Jinhu
LI Dawei
Hyalu
r
onic acid-
r
ebamipide conjugate
R
ebamipide
Nanopa
r
ticles
Details
Efficacy of calcitriol soft capsules combined with progressive resistance training in senile sarcopenia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1132-1139.
5129 times
534 times
CHEN Juan
CHEN Xiufang
WANG Xiaoxue
LU Sujuan
YE Danru
CHEN Wenwen
Calcit
r
iol soft capsules
P
r
og
r
essive
r
esistance t
r
aining
Sa
r
copenia
Inflammato
r
y facto
r
s
Details
Efficacy of Linggui Zhugan formula combined with food restriction therapy on patients with metabolic syndrome
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1140-1146.
5059 times
538 times
XIANG Yuyang
XIE Yuye
JIN Binbin
Linggui Zhugan fo
r
mula
Food
r
est
r
iction the
r
apy
Metabolic synd
r
ome
T
r
aditional Chinese medicine synd
r
ome
Metabolism
Details
Efficacy of Guanxinning combined with nimodipine tablets in the treatment of vascular dementia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1147-1154.
5186 times
536 times
XU An
WANG Zhuiqin
Guanxinning
Nimodipine tablets
Vascula
r
dementia
Details
Application analysis of butylphthalide combined with programmed intervention in patients with cerebrovascular disease-induced hemiplegia
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1155-1162.
4922 times
524 times
WANG Xuelian
LIU Ying
HU Rui
]LUO Wenjiao
Butylphthalide
P
r
og
r
ammed inte
r
vention
Ce
r
eb
r
ovascula
r
disease-induced hemiplegia
Neu
r
ological function
Moto
r
ability
Self-ca
r
e ability
Details
Efficacy and prediction model construction of aripiprazole combined with Sertraline in the treatment of adolescent depression
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1163-1171.
5328 times
553 times
YE Haiyan
CHEN Liang
MIN Guoqing
YE Xiaofang
A
r
ipip
r
azole
Se
r
t
r
aline
Adolescent dep
r
ession
T
r
eatment efficacy p
r
ediction model
Details
Influencing factors of abnormal liver function induced by enoxaparin sodium and construction of Logistic risk prediction model
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1172-1178.
4755 times
523 times
ZHOU Xiaoling
ZHAO Mengxi
HU Yali
XU Jing
Enoxapa
r
in sodium
Abno
r
mal live
r
function
R
isk facto
r
s
P
r
ediction model
Cumulative d
r
ug dose
Details
Cost-utility analysis of albumin paclitaxel combined with atezolizumab for the treatment of PD-L1-positive advanced triple-negative breast cancer
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1179-1185.
4977 times
566 times
HU Xiuping
TAN Lunan
LI Hongbo
YAO Huitao
Albumin paclitaxel
Atezolizumab
Pha
r
macoeconomics
Cost-utility analysis
Details
Analysis of immune checkpoint inhibitor induced hypothyroidism based on the U.S. FAERS database
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1186-1191.
4848 times
502 times
WANG Huiru
YANG Hua
REN Yanfei
CAO Zhibao
LI Xue
Immune checkpoint inhibito
r
s
Hypothy
r
oidism
FDA Adve
r
se Event
R
epo
r
ting System
D
r
ug vigilance
Details
Charcteristics and medication rules in pescriptions of Taiping Huimin Heji Jufang for external preparation based on data mining
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1192-1200.
4757 times
548 times
ZHANG Jianjun
HE Xueling
Taiping Huimin Heji Jufang
Exte
r
nal p
r
epa
r
ations
Function cha
r
acte
r
istics
Mian efficacy
Medication
r
ules
Data mining
Details
Application of QFD innovative quality control circle to construct a management model for chemotherapy-induced vomiting in oncology patients
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1201-1208.
5098 times
533 times
ZHANG Menghua
MEI Fei
XU Jie
LI Zhou
WANG Wanqing
GU Jihong
Chemothe
r
apy-induced nausea and vomiting
Quality cont
r
ol ci
r
cle
Quality function deployment
Pha
r
maceutical ca
r
e
Details
Construction and practice of individualized medication guidance for cardiovascular chronic disease patients based on informatization
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1209-1214.
4594 times
506 times
YU Tianjian
ZHANG Jing
YU Xiongjie
CHEN Jinhua
Ca
r
diovascula
r
d
r
ugs
Medication guidance
Info
r
matization const
r
uction
Individuation
Details
Bibliometric analysis of the research hotspots and trends related to Zheng Gan decoction
Published on
Frontiers in Pharmaceutical Sciences
2025,29(7):1215-1223.
4940 times
609 times
SONG Tianli
WANG Yiming
LIU Xu
XIANG Dehuang
HUANG Sheng
RAN Yun
Bibliomet
r
ics
Zheng Gan decoction
Hepatocellula
r
ca
r
cinoma
Anti-tumou
r
Apoptosis
Details
上一页
1
2
110
111
112
113
114
115
116
129
130
下一页